SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...

Centralizing diagnostics and medications can speed care. Locating the lab and pharmacy in a central hub shortens transit time ...

XPro™ is a next-generation, selective soluble TNF inhibitor designed to selectively neutralize soluble TNF (sTNF) and restore ...

UC Riverside researchers have developed an oxygen-delivering gel capable of healing injuries that might otherwise progress to ...

Boca Raton, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a late-stage biotechnology company focused on inflammation and immunology, will host a ...

Bradford (Pa.) Regional Medical Center, part of Buffalo, N.Y.-based Kaleida Health, plans to close its inpatient, emergency and long-term care services by mid-2026 and transition its campus to an ...

National Conversation to Address Emerging Risks and Opportunities “This webinar is designed for everyone, from ...

The webinar presentation will cover financial and business results from AVITA Medical’s recent fourth-quarter and full-year 2025 earnings webcast and will conclude with a Q&A session. Participants are ...

Auto Shop Orlando Experts Warn That Delaying Check Engine Light Diagnostics Can Lead to Costly Repairs ORLANDO, FL, ...

Researchers have developed a spray-on powder that turns into a wound-conforming gel when it comes in contact with blood. The breakthrough has the possibility of dramatically improving wound care in ...

In 2026, the global wound care market is expected to grow to approximately $24 billion in volume and continue its growth through 2032 at a compound annual growth rate (CAGR) of approximately seven per ...